• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦全国性研究中具有致病性变异的遗传性出血性毛细血管扩张症患者。

Hereditary haemorrhagic telangiectasia in Danish patients with pathogenic variants in a nationwide study.

机构信息

Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark

Department of Otorhinolaryngology HHT-Centre, Odense University Hospital, Odense, Denmark.

出版信息

J Med Genet. 2023 May;60(5):464-468. doi: 10.1136/jmg-2022-108766. Epub 2022 Aug 29.

DOI:10.1136/jmg-2022-108766
PMID:36038259
Abstract

BACKGROUND AND AIMS

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant condition characterised by recurrent epistaxis, telangiectatic lesions in the skin and mucosal membranes, and arteriovenous malformations (AVMs) in various organs. In 3%-5% of patients, HHT is caused by pathogenic germline variants (PVs) in , and these patients often have additional symptoms of juvenile polyposis syndrome and thoracic aneurysms. The phenotypic spectrum of -associated HHT is less known, including the penetrance and severity of HHT. We aimed to investigate the phenotypic spectrum of HHT manifestations in Danish patients with PVs in and compare the findings with current literature.

METHODS

The study is a retrospective nationwide study with all known Danish patients with PVs in . In total, 35 patients were included. The patients were identified by collecting data from genetic laboratories, various databases and clinical genetic departments across the country. Clinical information was mainly collected from the Danish HHT-Centre at Odense University Hospital.

RESULTS

Twenty-nine patients with PVs in (83%) were seen at the HHT-Centre. Seventy-six per cent of these fulfilled the Curaçao criteria, 86% experienced recurrent epistaxis and 83% presented with telangiectatic lesions at different anatomical localisations. Almost 60% had AVMs, mainly pulmonary and hepatic, while none was found to have cerebral AVMs. Fifteen per cent had thoracic aortic abnormalities.

CONCLUSION

We present a nationwide study of one of the largest populations of patients with PVs in that has systematically been examined for HHT manifestations. The patients presented the full spectrum of HHT-related manifestations and the majority fulfilled the Curaçao criteria.

摘要

背景和目的

遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性遗传疾病,其特征为反复发作的鼻出血、皮肤和黏膜毛细血管扩张以及各种器官的动静脉畸形(AVM)。在 3%-5%的患者中,HHT 是由 中的致病性种系变异(PVs)引起的,这些患者通常还具有青少年息肉综合征和胸动脉瘤的其他症状。 相关 HHT 的表型谱知之甚少,包括 HHT 的外显率和严重程度。我们旨在研究丹麦 中携带 PVs 的 HHT 患者的表型谱,并将研究结果与现有文献进行比较。

方法

这是一项全国性的回顾性研究,包括丹麦所有已知的 中携带 PVs 的患者。共纳入 35 例患者。通过从全国的遗传实验室、各种数据库和临床遗传科收集数据来识别患者。临床信息主要从奥胡斯大学医院丹麦 HHT 中心收集。

结果

29 例(83%)携带 中 PVs 的患者在 HHT 中心就诊。这些患者中有 76%符合 Curaçao 标准,86%反复发作鼻出血,83%在不同解剖部位出现毛细血管扩张病变。近 60%有 AVM,主要为肺和肝,而无脑 AVM。15%有胸主动脉异常。

结论

我们进行了一项全国性研究,纳入了 中携带 PVs 的患者中最大的人群之一,并对其进行了 HHT 表现的系统检查。这些患者表现出了与 HHT 相关的所有表现谱,大多数患者符合 Curaçao 标准。

相似文献

1
Hereditary haemorrhagic telangiectasia in Danish patients with pathogenic variants in a nationwide study.丹麦全国性研究中具有致病性变异的遗传性出血性毛细血管扩张症患者。
J Med Genet. 2023 May;60(5):464-468. doi: 10.1136/jmg-2022-108766. Epub 2022 Aug 29.
2
Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.ENG、ACVRL1 和 SMAD4 基因突变与遗传性出血性毛细血管扩张症的临床表现:来自乌普萨拉大学医院奥尔斯勒病中心的经验。
Ups J Med Sci. 2018 Sep;123(3):153-157. doi: 10.1080/03009734.2018.1483452. Epub 2018 Sep 25.
3
JP-HHT phenotype in Danish patients with SMAD4 mutations.丹麦携带SMAD4突变患者的JP-HHT表型
Clin Genet. 2016 Jul;90(1):55-62. doi: 10.1111/cge.12693. Epub 2015 Dec 21.
4
Phenotypic characterisation of variant carriers.变异携带者的表型特征分析。
J Med Genet. 2024 Jul 19;61(8):734-740. doi: 10.1136/jmg-2023-109632.
5
The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome.遗传性出血性毛细血管扩张症在青少年息肉综合征中的患病率。
Dis Colon Rectum. 2012 Aug;55(8):886-92. doi: 10.1097/DCR.0b013e31825aad32.
6
SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia.SMAD4 突变与青少年息肉综合征和遗传性出血性毛细血管扩张症的联合综合征。
Thorax. 2010 Aug;65(8):745-6. doi: 10.1136/thx.2009.129932.
7
Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.遗传性出血性毛细血管扩张症患者的临床和分子特征:来自 HHT 卓越中心的经验。
Am J Med Genet A. 2021 Jul;185(7):1981-1990. doi: 10.1002/ajmg.a.62193. Epub 2021 Mar 26.
8
Prevalence of thoracic aortopathy in patients with juvenile Polyposis Syndrome-Hereditary Hemorrhagic Telangiectasia due to SMAD4.因SMAD4导致的幼年性息肉综合征-遗传性出血性毛细血管扩张症患者胸主动脉病变的患病率。
Am J Med Genet A. 2015 Aug;167A(8):1758-62. doi: 10.1002/ajmg.a.37093. Epub 2015 Apr 30.
9
Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.韩国遗传性出血性毛细血管扩张症患者ENG、ACVRL1和SMAD4基因的临床特征及突变情况
J Korean Med Sci. 2009 Feb;24(1):69-76. doi: 10.3346/jkms.2009.24.1.69. Epub 2009 Feb 28.
10
Digital Clubbing in Hereditary Hemorrhagic Telangiectasia/Juvenile Polyposis Syndrome.遗传性出血性毛细血管扩张症/青少年息肉综合征的杵状指(趾)。
Acta Dermatovenerol Croat. 2021 Apr;291(1):56-57.

引用本文的文献

1
Acute aortic dissection in a patient with Hereditary Hemorrhagic Telangiectasia associated with Juvenile Polyposis due to SMAD4 mutation: case report and literature review.1例因SMAD4突变导致遗传性出血性毛细血管扩张症合并幼年性息肉病患者的急性主动脉夹层:病例报告及文献复习
Angiogenesis. 2025 May 2;28(3):27. doi: 10.1007/s10456-025-09981-9.
2
Overlap syndrome of hereditary hemorrhagic telangiectasia and juvenile polyposis syndrome: ten years follow-up-case series and review of literature.遗传性出血性毛细血管扩张症与幼年性息肉综合征重叠综合征:十年随访病例系列及文献复习。
Fam Cancer. 2024 Nov 15;24(1):1. doi: 10.1007/s10689-024-00425-9.
3
Outcomes of patients with Juvenile Polyposis-Hereditary Haemorrhagic Telangiectasia caused by pathogenic SMAD4 variants in a pan-Scotland cohort.
苏格兰泛群中由致病性 SMAD4 变异引起的幼年性息肉病-遗传性出血性毛细血管扩张症患者的结局。
Eur J Hum Genet. 2024 Jun;32(6):731-735. doi: 10.1038/s41431-024-01607-w. Epub 2024 Apr 16.
4
Phenotypic characterisation of variant carriers.变异携带者的表型特征分析。
J Med Genet. 2024 Jul 19;61(8):734-740. doi: 10.1136/jmg-2023-109632.
5
Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症患者抗凝处方的药物基因组学考量
J Clin Med. 2023 Dec 15;12(24):7710. doi: 10.3390/jcm12247710.
6
Whole genome sequencing and disease pattern in patients with juvenile polyposis syndrome: a nationwide study.全基因组测序与青少年息肉病综合征患者的疾病谱:一项全国性研究。
Fam Cancer. 2023 Oct;22(4):429-436. doi: 10.1007/s10689-023-00338-z. Epub 2023 Jun 24.
7
Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia.遗传性出血性毛细血管扩张症肝脏受累的诊断和管理现行指南。
World J Hepatol. 2023 May 27;15(5):675-687. doi: 10.4254/wjh.v15.i5.675.
8
Hereditary polyposis syndromes remain a challenging disease entity: Old dilemmas and new insights.遗传性息肉病综合征仍然是一个具有挑战性的疾病实体:旧困境与新见解。
World J Gastrointest Surg. 2023 Jan 27;15(1):1-8. doi: 10.4240/wjgs.v15.i1.1.